Founded in April 2010 as a spin-off from the Institute of Biotechnology and Nanotechnology, HistoIndex is dedicated to addressing the significant unmet medical need of NASH, a chronic liver disease linked to unhealthy lifestyles. By leveraging their imaging systems based on Second Harmonic Generation (SHG) and Two-Photon Excitation (TPE), HistoIndex is setting new medical standards for clinical research, pharmaceutical drug development, and clinical diagnostics. Their digital pathology platform enables efficient and effective diagnoses of chronic liver conditions, offering stain-free, three-dimensional, quantitative imaging for visualizing and staging fibrosis.